Search
SOLACI Congress
HomeFileStructural heart disease

Structural heart disease

View Category

Other

OBSERVANT II: Post TAVR 30-Day and 6-Month Stroke Predictors

Despite stroke rate has declined since the early days of transcatheter aortic valve replacement (TAVR), it remains...
solaci -
Learn More
Structural heart disease

Cause of Cardiac Death after TAVR at Present

Cardiac failure (CF) and sudden cardiac death (SCD) stand out as two of the main causes of...
solaci -
Learn More
Other

Transcatheter Closure of Patent Foramen Ovale in Thrombophilia Patients

The transcatheter treatment of patent foramen ovale (PFO) has been shown to reduce thromboembolic events in patients...
solaci -
Learn More
Structural heart disease

TAVR in Asymptomatic or Minimally Symptomatic Patients: 30-Day Results

Aortic valve replacement (AVR) is recommended for symptomatic aortic stenosis (AS), while close monitoring is the advised...
solaci -
Learn More
Mitral valve

MITRAL Trial, Results at 5 Years

Repeat mitral valve repair has been associated with increased mortality. Transcatheter mitral valve repair has surged as...
solaci -
Learn More
Structural heart disease

TriClip: Good Outcomes After a 2-Year Follow-up

Severe tricuspid regurgitation (TR) is an underestimated condition in healthcare systems. However, it is more common than...
solaci -
Learn More
Mitral valve

TRILUMINATE Two Years In: Encouraging Results

Tricuspid valve regurgitation is more common than one might think. It often stems from left valve disease...
solaci -
Learn More
Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy: Long Term Survival with Alcohol Septal Ablation according to Hemodynamic Variables

Left ventricular outflow tract (LVOT) obstruction is an integral component of hypertrophic cardiomyopathy (HCM). Both chemical myomectomy...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy